Article
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design.
Cell - 1 Nov 2018
Dong Yin Yao, Wang Hua, Pike Ashley C W, Cochrane Stephen A, Hamedzadeh Sadra, Wyszyński Filip J, Bushell Simon R, Royer Sylvain F, Widdick David A, Sajid Andaleeb, Boshoff Helena I, Park Yumi, Lucas Ricardo, Liu Wei-Min, Lee Seung Seo, Machida Takuya, Minall Leanne, Mehmood Shahid, Belaya Katsiaryna, Liu Wei-Wei, Chu Amy, Shrestha Leela, Mukhopadhyay Shubhashish M M, Strain-Damerell Claire, Chalk Rod, Burgess-Brown Nicola A, Bibb Mervyn J, Barry Iii Clifton E, Robinson Carol V, Beeson David, Davis Benjamin G, Carpenter Elisabeth P
Abstract excerpt
Protein N-glycosylation is a widespread post-translational modification. The first committed step in this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 2.7.8.15). Missense DPAGT1 variants cause congenital myasthenic syndrome and disorders of glycosylation. In addition, naturally-occurring bactericidal nucleoside analogues such as tunicamycin are toxic to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
